sintx.com (SINT) Narxning foydaga nisbati
Sintx Technologies (SINT) uchun bozor tendentsiyasi -1.00 qiymatini namoyish etmoqda, bu esa noyob kremniy nitridi sertifikatsiya darajasida B2B hamkorlarini ta'minlaydigan yuqori texnologiyali biokeramika muhitining yaratilishi bilan bog'liq. Moliyaviy barqarorlik protez komponentlarining tizimli yetkazib berishiga asoslangan. Biznes hozirda yetuk bosqichda bo'lib, o'z materiallaridan energetika sektori va zirh ishlab chiqarishda foydalanishni kengaytirmoqda.
Sintx Technologies Inc (SINT) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
- balans kapitallashuvi haqida ma'lumot:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning kapitalga nisbati Sintx Technologies|SINT - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi SINTX Technologies|SINT - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Sintx Technologies, Inc.|SINT - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari Sintx Technologies|Shoshilinch likvidlik sintx.com
- foyda va bozor multiplikatorlari tafsilotlari:
SINT - Sof foyda|Sof foyda prognozi Sintx Technologies|SINT - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati SINTX Technologies|SINT - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Sintx Technologies, Inc.|SINT - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Sintx Technologies|SINT - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi sintx.com|SINT - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Sintx Technologies
Kompaniyaning umumiy tahlili:sintx.com - SINT
Sintx Technologies (SINT) texnologik yetakchilikka intilmoqda, biroq keramika implantlariga bo'lgan talabning kamayishi va materiallarni tijoratlashtirish bilan bog'liq qiyinchiliklar daromadlilikka sezilarli bosim o'tkazmoqda. Aksiyaning bozor qiymatining yillik foydaga nisbati, emissiyaning P/E koeffitsiyentida aks etgan holda, aktivning haddan tashqari qimmat baholanganligini baholash va uning samaradorligini AQSh bozorining sanoat standartlari bilan solishtirish imkonini beradi.
Raqobatdosh kompaniyalar tahlili
P/E multiplikatori bostonscientific.com|Narxning foydaga nisbati Edwards Lifesciences Corporation (EW)|Narxning foydaga nisbati RMD (ResMed Inc)|P/E multiplikatori PODD (OmniPod)|Biznesning o‘zini qoplash muddati Zimmer Biomet (ZBH)|COO: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati ALGN|GMED: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati TransMedics Organ Care System (TMDX)|ATEC (ATEC Spine) - P/E multiplikatori|Narx-foyda multiplikatori AORT (Artivion Corp)|Narx-foyda koeffitsiyenti ENOV (Enovis Corporation)|IART (integralife.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Establishment Labs Holdings Inc. ESTA|BBNX - Narx-foyda koeffitsiyenti|Iradimed - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Embecta Health|TNDM: P/E multiplikatori|Narx-foyda multiplikatori AXGN|SIBN (SI-BONE) - P/E multiplikatori|Orthofix Medical (OFIX) - Biznesning o‘zini qoplash muddati|P/E multiplikatori BVS|Narx-foyda koeffitsiyenti orthopediatrics.com KIDS|P/E multiplikatori TMCI (Treace Medical Concepts)|P/E multiplikatori blade.com SRTA|CARL - Narxning foydaga nisbati|RXST: Narxning foydaga nisbati|CLPT (clearpointneuro.com) - Narx-foyda koeffitsiyenti|Stereotaxis Corporation - Kompaniya qiymatining sof foydaga nisbati|STIM (Neuronetics, Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati sightsciences.com SGHT|Narxning foydaga nisbati Orchestra BioMed, Inc. (OBIO)|anikatherapeutics.com (ANIK) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|InspireMD Corp - Narx-foyda koeffitsiyenti|P/E multiplikatori Jin Medical International Ltd. ZJYL|Vivani - P/E multiplikatori|Biznesning o‘zini qoplash muddati Xtant Medical Holdings XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati MODD (Modular Medical, Inc.)|Narxning foydaga nisbati Myomo, Inc|Narx-foyda koeffitsiyenti Envoy Medical Inc (COCH)|P/E multiplikatori VVOS|NVNO - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Tenon Medical TNON|LFWD: Narx-foyda multiplikatori|AMIX: Narx-foyda koeffitsiyenti|INVO Fertility Corp - Bozor narxining sof foydaga nisbati|Bone Biologics (BBLG) - Narxning foydaga nisbati|AXNX - Biznesning o‘zini qoplash muddati|BIOL (BIOLASE) - P/E multiplikatori|Dynatronics Corp. (DYNT) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Paragon 28, Inc. (FNA)|invobioscience.com - Narx-foyda multiplikatori
